Phathom Pharmaceuticals (PHAT) Treasury Shares (2019 - 2026)
Phathom Pharmaceuticals (PHAT) posted quarterly Treasury Shares of $3.1 million for Q2 2026, up 17.25% year-over-year from $2.6 million in Q2 2025, and up 3.89% quarter-over-quarter from $3.0 million in Q1 2026.
Phathom Pharmaceuticals (PHAT) Treasury Shares (2019 - 2026) Analysis & Trends
Phathom Pharmaceuticals (PHAT) has reported Treasury Shares for 8 consecutive years, with $3.1 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Treasury Shares rose 17.25% year-over-year to $3.1 million; the TTM figure through Jun 2026 stood at $3.1 million (up 17.25% YoY), while the FY2025 annual figure was $2.2 million, down 9.57% from the prior year.
- Treasury Shares advanced to $3.1 million in Q2 2026 per PHAT's latest filing, from $3.0 million in the prior quarter.
- Across five years, Treasury Shares topped out at $3.3 million in Q1 2025 and bottomed at $19.0 in Q2 2023.
- Historically, Treasury Shares has averaged $1.5 million across 5 years, with a median of $1.5 million in 2022.
- Annual changes were most pronounced in 2023 — Treasury Shares tumbled 100.0% — and 2024, when it jumped 15313463.16%.
- Phathom Pharmaceuticals' Treasury Shares stood at $254437.0 in 2022, then tumbled by 99.99% to $19.0 in 2023, then changed by 0.0% to $19.0 in 2024, then soared by 11339815.79% to $2.2 million in 2025, then jumped by 43.31% to $3.1 million in 2026.
- Business Quant data shows PHAT's Treasury Shares at $3.1 million in Q2 2026, $3.0 million in Q1 2026, and $2.2 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.08 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.72 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 92,219.00 |
| 10 | Phathom Pharmaceuticals | 767.07 Mn | 581.73 Mn | 59.18 Mn | 3.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.09 Mn |
| Jun 30, 2026 | 3.09 Mn |
| Mar 31, 2026 | 2.97 Mn |
| Mar 31, 2026 | 2.97 Mn |
| Dec 31, 2025 | 2.15 Mn |
| Dec 31, 2025 | 2.15 Mn |
| Sep 30, 2025 | 667,775.00 |
| Sep 30, 2025 | 667,775.00 |
| Jun 30, 2025 | 2.63 Mn |
| Jun 30, 2025 | 2.63 Mn |
| Mar 31, 2025 | 583,800.00 |
| Mar 31, 2025 | 583,800.00 |
| Dec 31, 2024 | 19.00 |
| Dec 31, 2024 | 19.00 |
| Sep 30, 2024 | 19.00 |
| Sep 30, 2024 | 19.00 |
| Jun 30, 2024 | 2.91 Mn |
| Jun 30, 2024 | 2.91 Mn |
| Mar 31, 2024 | 19.00 |
| Mar 31, 2024 | 19.00 |